[1]Jaye M,Lynch KJ,Krawiec J, et al.A novel endothelial-derived lipase that modulates HDL metabolism[J].Nat Genet,1999,2:424-428. [2]Liu C,Dhindsa D,Almuwaqqat Z, et al.Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations[J].JAMA Cardiol,2022,7:672-680. [3]Yang S,Yin RX,Miao L, et al.LIPG SNPs, their haplotypes and gene-environment interactions on serum lipid levels[J].Lipids Health Dis,2019,18:10.doi:10.1186/s12944-018-0942-y. [4]Nagao M,Miyashita K,Mori K, et al.Serum concentration of full-length-and carboxy-terminal fragments of endothelial lipase predicts future cardiovascular risks in patients with coronary artery disease[J].J Clin Lipidol,2019,13:839-846. [5]其布热,周红,董莉.内皮酯酶基因多态性与冠心病的关系研究[J].临床和实验医学杂志,2019,18:699-703. [6]Schilcher I,Kern S,Hrzenjak A, et al.Impact of endothelial lipase on cholesterol efflux capacity of serum and high-density lipoprotein[J].Sci Rep,2017,7:12485.doi:10.1038/s41598-017-12882-7. [7]Khetarpal SA,Vitali C,Levin MG, et al.Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins[J].PLoS Genet,2021,17:e1009802.doi:10.1371/journal.pgen.1009802. [8]Wu L,Soundarapandian MM,Castoreno AB, et al.LDL-cholesterol reduction by angptl3 inhibition in mice is dependent on endothelial lipase[J].Circ Res,2020,127:1112-1114. [9]Wang C,Nishijima K,Kitajima S, et al.Increased hepatic expression of endothelial lipase inhibits cholesterol diet-induced hypercholesterolemia and atherosclerosis in transgenic rabbits[J].Arterioscler Thromb Vasc Biol,2017,37:1282-1289. [10]Wu YE,Ma L,Zhang H, et al.Significant association between the endothelial lipase gene 584C/T polymorphism and coronary artery disease risk[J].Biosci Rep,2020,40.doi:10.1042/BSR20200027. [11]Schilcher I,Stadler JT,Lechleitner M, et al.Endothelial lipase modulates paraoxonase 1 content and arylesterase activity of HDL[J].Int J Mol Sci,2021,22.doi:10.3390/ijms22020719. [12]陈永宏,杨松,周建中.阿托伐他汀减轻肾性高血压大鼠血管重构[J].基础医学与临床,2010,30:383-388. [13]Trimarco V,Izzo R,Morisco C, et al.High HDL(high-density lipoprotein) cholesterol increases cardiovascular risk in hypertensive patients[J].Hypertension,2022,79:2355-2363. [14]Yue X Wu M,Jiang H, et al.Endothelial lipase is upregulated by interleukin-6 partly via the p38 MAPK and p65 NF-κB signaling pathways[J].Mole Med Reports,2016,14: 1979-1985. [15]Dalan AB,Toptaş B,Buǧra Z, et al.The effects of endothelial lipase gene (LIPG) variants on inflammation marker levels and atherosclerosis development[J].Mol Biol Rep,2013,40:5143-5149. [16]Cadenas C,Vosbeck S,Edlund K, et al.LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer[J].Int J Cancer,2019,145:901-915. [17]Nakajima H,Ishida T,Satomi-Kobayashi S, et al.Endothelial lipase modulates pressure overload-induced heart failure through alternative pathway for fatty acid uptake[J].Hypertension,2013,61:1002-1007. [18]Schilcher I,Ledinski G,Radulović S, et al.Endothelial lipase increases antioxidative capacity of high-density lipoprotein[J].Biochim Biophys Acta Mol Cell Biol Lipids,2019,1864:1363-1374. [19]Wan A,Rodrigues B.Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy[J].Cardiovasc Res,2016,111:172-183. [20]Yan H,Niimi M,Wang C, et al.Endothelial lipase exerts its anti-atherogenic effect through increased catabolism of β-VLDLs[J].J Atheroscler Thromb,2021,28:157-168. [21]Kobayashi J.Which is the Best predictor for the develop-ment of atherosclerosis among circulating lipoprotein lipase, hepatic lipase, and endothelial lipase?[J].J Atheroscler Thromb,2019,26:758-759. [22]Yu X,Lu J,Li J, et al.Serum triglyceride lipase concentrations are independent risk factors for coronary artery disease and in-stent restenosis[J].J Atheroscler Thromb,2019,26:762-774. [23]Tora G,Kim SH,Pi Z, et al.Identification of reversible small molecule inhibitors of endothelial lipase (EL) that demonstrate HDL-C increase in vivo[J].J Med Chem,2020,63:1660-1670. [24]Johnson JA,Tora G,Pi Z, et al.Sulfonylated benzothia-zoles as inhibitors of endothelial lipase[J].ACS Med Chem Lett,2018,9:1263-1268. [25]Ruff CT,Koren MJ,Grimsby J, et al.LEGACY: phase 2a trial to evaluate the safety, pharmacokinetics, and pharmacodynamic effects of the anti-EL(endothelial lipase) antibody MEDI5884 in patients with stable coronary artery disease[J].Arterioscler Thromb Vasc Biol,2021,41:3005-3014. [26]Meng W,Adam LP,Behnia K, et al.Benzothiazole-based compounds as potent endothelial lipase inhibitors[J].Bioorg Med Chem Lett,2019,29:126673.doi:10.1016/j.bmcl.2019.126673. |